|
Delayed
TEL AVIV STOCK EXCHANGE
10:24:54 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 116.60 ILa | -0.68% |
|
-4.03% | -61.21% |
| 10-06 | Evogene Enters into Cooperation Agreement with L.I.A. Pure Capital | CI |
| 10-06 | Evogene Ltd. Announces Appointment of Pure Capital Group Nominee Directors | CI |
Company Valuation: Evogene Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 6 | - | - |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -27% | - | - |
| Enterprise Value (EV) | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 6 | 6 | 6 |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -27% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 76.6x | 15.6x | 7.46x | 1.53x | 2.13x | 4.18x | 2.31x | 1.21x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.18x | 2.31x | 1.21x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -0.67x | -0.67x | -0.65x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.59x | -0.59x | -0.56x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.93 | 1.675 | 5.64 | 8.511 | 3.853 | 1.436 | 2.6 | 4.95 |
| EBITDA 1 | - | - | -22.04 | -17.39 | -12.89 | -9.008 | -8.9 | -9.178 |
| EBIT 1 | -30.95 | -26.94 | -26.51 | -22.21 | -14.03 | -10.14 | -10.2 | -10.63 |
| Net income 1 | -27.79 | -26.64 | -23.88 | -16.48 | -8.485 | -12.17 | -10.2 | -10.63 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 53.750 | 22.350 | 29.980 | 7.269 | 3.006 | 1.174 | 1.174 | 1.174 |
| Nbr of stocks (in thousands) | 4,116 | 4,122 | 5,055 | 6,515 | 8,716 | 15,801 | - | - |
| Announcement Date | 3/10/22 | 3/9/23 | 3/7/24 | 3/6/25 | 3/5/26 | - | - | - |
1USD in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 6M | |
| 19.21x | 6.83x | 13.69x | 1.55% | 66.34B | |
| 36.32x | 6.47x | 19.31x | 0.89% | 52.92B | |
| 29.51x | 8.11x | 25.65x | 0.05% | 54.82B | |
| 34.13x | 3.33x | 14.37x | -.--% | 44.09B | |
| 50.62x | 5.85x | 32.15x | -.--% | 43.72B | |
| -20.41x | 209.35x | -21.69x | -.--% | 42.13B | |
| 29.48x | 8.35x | 21.6x | 0.36% | 33.96B | |
| 30.25x | 6.41x | 16.63x | -.--% | 26.17B | |
| 31.94x | 5.89x | 19.81x | -.--% | 23.37B | |
| Average | 26.78x | 28.95x | 15.73x | 0.32% | 38.75B | |
| Weighted average by Cap. | 26.35x | 28.52x | 15.73x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVGN Stock
- Valuation Evogene Ltd.
Select your edition
All financial news and data tailored to specific country editions
